cancel
Showing results for 
Search instead for 
Did you mean: 
Orbitrap_SciLib
Reputable Mentor II
Reputable Mentor II

Quantitation of drugs of abuse in body fluids is challenging due to the varying concentrations and substantially different chemical and physical properties of the drugs, interfering matrices, occasionally small volumes of sample to test, and the presence of many similar compounds. Further, constant evolution of drugs makes it harder to identify and quantitate them. Currently, most of the quantitative analysis is done using a selected reaction monitoring (SRM) approach on a triple-stage quadrupole mass spectrometer. This approach is inherently targeted and misses new compounds. Also, the SRM duty cycle limits monitoring, and quantitating large numbers of analytes is very difficult if not impossible. For the first time, high-resolution, accurate mass spectrometry based on Orbitrap™ technology offers a practical solution for the challenge at hand. The high resolution of up to 140,000 FWHM enables separation of drugs and metabolites from interferences. Fast positive/negative switching catches acidic, basic and neutral drugs. Better than 3 ppm mass accuracy assures confidence in identification, and fragment ions from the HCD cell further confirm the identity beyond a reasonable doubt. All of this is made simple by using Thermo Scientific TraceFinder and ExactFinder software, which help attain high productivity and confidence in routine targeted and general unknown screening applications.
 
Here we describe the application of Orbitrap technology-based workflow solutions for quantitation of drugs and metabolites in urine, plasma, whole blood, and oral fluid matrices.

For additional resources, search the Orbitrap Science Library 1GoArrow.png

Overview

Workflow Overview for Amphetamines

 
Quantitation of amphetamines in urine and plasma is of great importance for forensic toxicologists. The analytical workflow must be capable of handling highly polar isobaric/isomeric molecules, matrix interferences, wide dynamic ranges and significant sample-to-sample differences caused by the varying nature of the matrix.
 
The workflow described here involves enzymatic hydrolysis followed by methanol dilution for sample preparation. It uses simple full-scan MS at 70,000 to 100,000 FWHM resolution. The LLOQ obtained is about 1 ng/mL, with a ULOQ of 1,000 ng/mL.



 
Workflows_DOA_QUAN_AMPH(2).jpg


 

resources

 

Analysis of Expanded NIDA 5 panel Using Exactive System

He K.
Slide Presentation

 

Sample Preparation

Sample Preparation Workflow for Amphetamines

 
The sample preparation involves enzymatic hydrolysis, dilution followed by vortexing, and centrifugation. The sample preparation procedure can be scaled up to a 500 µL sample volume for ideal performance.

MWorkflows_AmphetaminesSP_(3).jpg

 

resources

 

Analysis of Expanded NIDA 5 panel Using Exactive System

He K.
Slide Presentation

 

Data Analysis

Data Analysis Workflow for Amphetamines

 
Thermo Scientific TraceFinder software was used for quantitation. The software extracts chromatograms using accurate m/z, identifies detected peaks using retention time, and quantitates using the area under the peaks.
 
MWorkflows_DOAQuan_DA_(1).jpg

resources

 

Analysis of Expanded NIDA 5 panel Using Exactive System

He K.
Slide Presentation

 

Mass Spectrometry

Mass Spectrometry Workflow for Amphetamines

 
A Thermo Scientific Exactive Plus mass spectrometer with a HESI source was coupled to a Thermo Scientific Accela 1250 uHPLC system. The MS was operated in Full Scan MS mode at a resolution of 70,000 – 100,000 FWHM. The column eluent was diverted to waste for a specified period of time after the sample injection before being sent to the MS. The Exactive Plus™ MS was calibrated at the beginning of the day and used for the entire analysis. No lock mass or internal calibration was used.
 

Scheme-ExactivePlus-Part-RGB.png

resources

 

Analysis of Expanded NIDA 5 panel Using Exactive System

He K.
Slide Presentation

 

Version history
Last update:
‎10-15-2021 11:48 AM
Updated by:
Closed Account
Contributors